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Abstract 1 
Objectives: To analyze clinical, esthetic, radiographic and prosthetic outcomes 2 
of implants and implant-supported reconstructions using two types of dental 3 
implants with non-matching implant abutment junctions. 4 
Materials and methods: 64 patients in need of dental implant therapy with 5 
fixed reconstructions were consecutively enrolled. They were randomly assigned 6 
to either one of two implant systems (S1: Straumann Bone Level and S2: 7 
Osseospeed Astra Tech). Baseline (day of loading) and one-year measurements 8 
included demographics, radiographic, clinical, biological, prosthetic and esthetic 9 
outcomes. All data were analyzed at the patient and at the implant level. The 10 
non-parametric Mann-Whitney-test was used to detect differences in continuous 11 
variables between two independent groups. 12 
Results: Ninety-seven implants (S1=54, S2=43) were placed and loaded with 13 
fixed reconstructions in 64 patients. No implant was lost during the one-year 14 
observation period resulting in a 100% survival rate for both implant systems. At 15 
the patient-level, the mean marginal bone level at implant insertion was -16 
1.30mm (SD ± 1.00mm) for S1 and -1.26mm (± 1.22mm) for S2 (negative 17 
values indicating bone levels coronal to the implant shoulder). At the time of 18 
loading, these distances measured 0.29mm (± 0.44mm) for S1 and 0.22mm (± 19 
0.43mm) for S2. At the one-year follow up, these distances were 0.37mm (± 20 
0.39mm) for S1 and 0.39mm (± 1.02mm) for S2. Technical complications of the 21 
reconstructions only occurred in group S1, with a rate of 12% (patient-level) 22 
 3 
 
(p>0.05). Biological complications were observed at a rate of 6% (S1) and 3.2% 1 
(S2) at the patient-level (p>0.05).  2 
Conclusions: Both implant systems revealed 100% survival rates and minimal 3 
changes of the marginal bone levels during one year of loading. Few technical 4 
and biological complications occurred. Therefore, both implant systems can be 5 
recommended for fixed reconstructions. 6 
 7 
 8 
 4 
 
Introduction 1 
Dental implants are a viable treatment option to restore function and esthetics in 2 
the oral cavity. Over time, the numbers of implants and implant systems 3 
available on the market greatly increased. A clinician today is confronted with 4 
hundreds of possible implant systems and designs to select from. Obvious 5 
factors, such as surgical and prosthetic options, survival and success rates as 6 
well as overall costs, form the basis for the clinician's decision-making for the 7 
choice of an implant system (Antonarakis, et al. 2014, Vogel, et al. 2013, 8 
Zitzmann, et al. 2013). 9 
 The main differences among the available systems consist in the variety of 10 
implant designs and surfaces. In general, two main implant types are available; 11 
one-piece and two-piece implants. For the latter, two types exist: i) with 12 
matching implant-abutment junction; ii) with non-matching implant abutment 13 
junction. The design of the implant-abutment junction appears to be a critical 14 
factor with respect to the initially occurring marginal bone loss following implant 15 
placement (Cardaropoli, et al. 2006, Prosper, et al. 2009). Long-term results of 16 
clinical studies demonstrated favorable maintenance of the marginal bone level 17 
with initially minimal bone loss for implants with a non-matching implant-18 
abutment (Astrand, et al. 2004, Gotfredsen 2004, Palmer, et al. 2000).  19 
 These more favorable (in terms of the initial marginal bone loss) results 20 
using a non-matching implant-abutment junction design may in part be 21 
explained by an increased distance between the bone and the microgap and 22 
fewer micromovements due to the internal conical connection between implant 23 
 5 
 
and abutment (Abrahamsson, et al. 2003, Hansson 2000, Hansson 2003, 1 
Hermann, et al. 2001, Jung, et al. 2008, Rasmusson, et al. 2001). These 2 
observations were confirmed by preclinical studies evaluating the influence of 3 
matching and non-matching implant abutment junctions (Broggini, et al. 2006, 4 
Heitz-Mayfield, et al. 2013, Hermann, et al. 1997). Currently, several dental 5 
implant systems offer two-piece dental implants with a non-matching implant-6 
abutment junction. Still, clinical data are scarce comparing two of these implant 7 
systems in a prospective controlled clinical study. 8 
 The aim of this present study was therefore, to analyze clinical, esthetic, 9 
radiographic and prosthetic outcomes of two types of dental implants with non-10 
matching implant-abutment junctions loaded with fixed implant-borne 11 
reconstructions.  12 
 13 
 6 
 
Materials and methods 1 
Study design 2 
This study was designed as a randomized controlled clinical trial at the Clinic of 3 
Fixed and Removable Prosthodontics and Dental Material Science Center of 4 
Dental Medicine, University of Zurich, Switzerland. The study protocol was 5 
approved by the local ethical committee. Sixty-four patients in need of dental 6 
implant therapy with fixed dental prostheses were consecutively enrolled in the 7 
study after signing the informed consent.  8 
 Enrolled patients were randomly allocated using a computer-generated 9 
randomization list to receive implants from one of the two systems (S1=Astra 10 
Tech OsseoSpeed®; ASTRA TECH Implant System, DENTSPLY Implants, 11 
Mölndal, Sweden; S2= Straumann Bone Level® Implants; Institut Straumann 12 
AG, Basel, Switzerland). 13 
The following inclusion criteria were applied:  14 
• patients had to be healthy and of legal age  15 
• no local jaw pathology 16 
• no periodontal disease (periodontal probing depths <4mm) 17 
• good oral hygiene (full mouth plaque index <25%) (O'Leary, et al. 18 
1972) 19 
• adequate control of inflammation (full mouth bleeding on probing 20 
<25%) (Ainamo & Bay 1975) 21 
• no restrictions were made with respect to the location of the implant(s) 22 
(upper/lower jaw, anterior/posterior sites) 23 
 7 
 
• implant therapy with fixed reconstructions  1 
No restrictions were made in terms of the need for bone regeneration prior to or 2 
simultaneously with implant placement. Patients not meeting the inclusion 3 
criteria were not considered for the study. 4 
 5 
Surgical procedure 6 
All surgical procedures were performed in accordance to the standard protocols 7 
of the respective implant systems provided and based on the manufacturers' 8 
recommendations. Generally, the implants were placed with the implant shoulder 9 
at the bone crest in both groups. Some implants were placed, for prosthetic 10 
reasons, with an increased sink depth (i.e. the implant shoulder was placed 11 
below the bone crest). Depending on the bony conditions and the location, the 12 
following implant types, lengths and diameters were used: S1 with diameters 13 
varying between 3.0 and 5.0 mm and lengths between 6 and 16 mm and S2 14 
with diameters varying between 3.3 and 4.8 mm and lengths between 6 and 14 15 
mm. All implants had a medium rough surface and a non-matching implant-16 
abutment junction. 17 
 In case of a dehiscence or a fenestration defect, a guided bone 18 
regeneration (GBR) procedure was applied. GBR was performed using 19 
demineralized bovine bone mineral (DBBM) (Bio-Oss Spongiosa®; Geistlich 20 
Pharma AG, Wolhusen, Switzerland). The DBBM was either covered with a 21 
resorbable (Bio-Guide®, Geistlich Parma AG) or a non-resorbable membrane 22 
(Gore-Tex®; W.L. Gore & Assoc., Flagstaff, AZ, USA). In some cases a synthetic 23 
biphasic calcium phosphate (BCP) consisting of a mixture of 60% hydroxyapatite 24 
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and 40% of beta-tricalcium phosphate (Straumann Bone Ceramic®, Institut 1 
Straumann AG, Basel, Switzerland) covered with a synthetic bioresorbable 2 
polyethylene glycol (PEG) hydrogel membrane (MembraGel®, Institut 3 
Straumann AG, Basel, Switzerland) was applied. The materials used depended 4 
on the clinical situation and the surgeon’s preference. 5 
At the end of the surgery a standardized peri-apical x-ray was taken. No 6 
restrictions were made with respect to the healing protocol (submerged vs. 7 
transmucosal healing) and the healing time before loading with the final 8 
reconstruction. 9 
 10 
Prosthetic procedure 11 
The prosthetic procedures were performed according to the guidelines of the 12 
individual implant systems. Screw-retained or cemented reconstructions were 13 
used based on the clinical situation and the clinician's expertise. 14 
The day of the insertion of the final prosthesis was considered as baseline (TP1). 15 
At the time of the baseline examination, all patients entered an individually 16 
designed maintenance program, which included regular dental hygiene sessions. 17 
One year after baseline examination, all patients were recalled for a one-year 18 
follow-up clinical examination.  19 
 20 
Outcome measures 21 
Implant and reconstruction survival rates as well as technical and biological 22 
complication rates (adverse events) for implants and reconstructions were 23 
calculated at the implant and patient level. 24 
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Radiographic assessment 1 
Standardized x-rays were made immediately after implant insertion, at baseline 2 
and at the one-year follow-up. The intraoral radiographs were obtained using a 3 
paralleling technique with Rinn-holders and analogue films (Kodak Ektaspeed 4 
Plus, Eastman Kodak and Co., Rochester, NY, USA). The x-rays were first 5 
digitalized and the marginal bone levels assessed at a 10x to 15x magnification 6 
using an open-source software (Image J; National Institutes of Health, Bethesda, 7 
MD, USA). The known distance between two implant threads was used to 8 
calibrate and determine the exact magnification of the individual images. The 9 
marginal bone level was examined at both the mesial and distal implant 10 
surfaces. This was done by measuring the distance between the flat top of the 11 
implant shoulder and the bone crest using a scale divided into 0.1 mm steps (= 12 
distance implant to bone, DIB). The marginal bone levels were measured at 13 
three time-points: 1. implant placement (TP0), 2. insertion of final prosthesis 14 
(TP1), 3. one-year follow-up examination (TP2). Marginal bone level changes 15 
were then calculated as differences between the three time-points. 16 
In addition, all implant-supported cantilever fixed dental prostheses (ICFDPs) 17 
were compared to non-cantilever fixed dental prostheses (nICFDPs) in both 18 
groups in order to evaluate the influence of the type of reconstruction on 19 
marginal bone level changes. Furthermore, the crown to implant ratios were 20 
measured at TP1 and TP2 and compared for both implant systems. 21 
 22 
 23 
 24 
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Clinical and esthetic parameters 1 
Clinical measurements were taken at six sites per implant (mesiobuccal, buccal, 2 
distobuccal, distolingual, lingual, and mesiolingual), at the neighbouring 3 
teeth/implant(s) and the contralateral tooth or implant using a periodontal probe 4 
(UNC-15, Hu-Friedy, Chicago, IL, USA). The parameters measured and the 5 
chronology of measurements were as follows: 6 
Probing pocket depth (PPD, mm), bleeding on probing (BOP, %), plaque control 7 
record (PCR,%) (O'Leary, Drake & Naylor 1972), recession (REC, mm) and the 8 
width of keratinized tissue on the buccal site of each implant (KMb, mm). 9 
Esthetic parameters included the papilla contour measurements mesially and 10 
distally (Jemt mes/Jemt dist,) (Jemt 1999) at the implant site(s). In addition, 11 
the papilla height (mesial papilla (PHm, mm), distal papilla (PHd, mm), and 12 
crown height (CH, mm) were assessed. The papilla height covered the distance 13 
between the tip of the papilla and the highest point of the incisal edge. The 14 
crown height was defined as the distance between the most apical point of the 15 
gingiva recession and the incisal edge. The thickness of the gingiva/mucosa was 16 
measured with an endodontic instrument (Hedstrom files #15, Dentsply 17 
Maillefer, Ballaigues, Switzerland) at a level 1mm below the margo mucosae 18 
(GT,mm). The changes for all biological and esthetic outcomes were evaluated 19 
statistically between TP1 and TP2 in both groups.  20 
 21 
Statistical analysis 22 
Data were recorded in Microsoft Excel spreadsheets (Microsoft" Corporation, 23 
Redmond, WA, USA) and analyzed in SPSS Version 19 (IBM; SPSS Inc., Chicago, 24 
 11 
IL, USA; SPSS" Statistics; SPSS Inc.). Descriptive statistics such as mean, 1 
median, standard deviation, interquartile range, minimum and maximum as well 2 
as absolute and relative frequencies were computed at the implant and patient 3 
level. For the implant-level analysis, one implant per patient was randomly 4 
selected for descriptive statistics. Chi2 and Fisher exact tests evaluated 5 
association between two discrete variables. On patient-level, the non-parametric 6 
Mann-Whitney test was used to detect a difference in a continuous variable 7 
between two independent groups (comparison S1 to S2). In addition, the non-8 
parametric paired Wilcoxon test assessed the influence of time between two 9 
continuous variables (analysis of the time-points), whereby these were 10 
evaluated non-parametrically by means of a Spearman correlation. Both a log-11 
rank test helped to analyze the survival rate of the implants on patient and 12 
implant level. Finally, results of the statistical analysis with p-values smaller than 13 
0.05 were considered statistically significant. 14 
 12 
Results 1 
Demographic data 2 
A total number of 64 patients (33 in group S1: 17 females and 16 males with 54 3 
implants; 31 in group S2: 21 females and 10 males with 43 implants) were 4 
included in the study. The mean age for group S1 was 55.0 years (SD±11.6 5 
years) and 54.3 years (SD±16.1 years) for group S2. All implants were inserted 6 
between February and December 2009. This included 68 implants placed in the 7 
upper jaw (S1: 34, S2: 34) and 29 in the lower jaw (S1: 20, S2: 9).  8 
The mean time between implant placement (TP0) and the insertion of the final 9 
prosthesis (TP1 – baseline) was 9.14 months for group S1 (SD± 4.47, range: 10 
min. 2.46 to max. 21.62 months) and 10.52 months for group S2 (SD± 4.61, 11 
range: min. 3.75 to max. 20.96 months). 12 
The mean time between prosthesis insertion and the one-year follow-up was 13 
15.57 months for group S1 (SD± 4.05, range: min. 8.21 to max. 19.94 months) 14 
and 15.80 months for group S2 (SD± 4.07, range: min. 10.55 to max. 23.55 15 
months).  16 
The prosthetic reconstructions (all of them fixed) included single crowns, splinted 17 
single crowns, fixed dental prostheses (FDPs) and implant-supported cantilever 18 
fixed dental prostheses (ICFDPs). An overview is given in Table 1.  19 
None of these demographic data did reveal any statistically significant 20 
differences between the two groups (p>0.05). 21 
 22 
 23 
 13 
Survival rate and success rates 1 
No implants were lost during the one-year observation period resulting in a 2 
100% survival rate for both implant systems. 3 
 4 
Implant-level analysis for adverse technical and biological events 5 
Technical complications occurred for seven S1 implants, but not for S2 implants. 6 
One implant/reconstruction (S1) was affected by three technical events 7 
(loosening of screw, a fractured screw and a chipping). Another implant was not 8 
restored following the fracture of a screw, which could not be removed. 9 
Therefore, the implant was left as a submerged sleeper. Further technical events 10 
included loosening of screws (n=4), fractured screws (n=5) and chipping of 11 
veneering ceramics (n=2).  12 
A total number of five biological events occurred. This included: mucositis with 13 
BOP at all six sites around the implant (S1 n= 2; S2 n=1); peri-implantitis with 14 
bone loss ≥ 2mm (S1 n=2).  15 
In total, a success rate of 81.5 % for S1 and of 95.3% for S2 could be reported 16 
on implant-level. 17 
 18 
Patient-level analysis for technical and biological events 19 
At the patient level, four technical events occurred on four implants (all S1 20 
implants). In addition, two biological events were observed in the S1 group (BOP 21 
at all six sites around one implant, and bone loss ≥ 2mm at another implant) 22 
and one in the S2 group (BOP at all six sites around the implant). The 23 
differences between the two groups were not statistically significant neither for 24 
 14 
technical (p=0.077) nor biological adverse events (p=0.591). At this level, the 1 
success rate was 81.8% for S1 and 96.8% for S2. 2 
 3 
Radiographic results 4 
Implant-level analysis 5 
The relative distances between the implant shoulder and the bone crest ranged 6 
between -4.01mm and 0.59mm (S1) and between -4.92mm and 0.65mm (S2). 7 
Negative values indicated that the implant shoulder was located more apically 8 
relative to the bone crest. The mean relative distance between the implant 9 
shoulder and the bone crest at implant placement was -1.07mm (SD ± 0.94mm) 10 
for S1 and -1.21mm (± 1.13mm) for S2. At the time of loading, this distance 11 
measured 0.39mm (± 0.53mm) for S1 and 0.21mm (± 0.40mm) for S2. At the 12 
one-year follow-up, these distances were 0.49mm (± 0.62mm) for S1 and 13 
0.34mm (± 0.88mm) for S2.  14 
A full overview is given in Table 2. 15 
 16 
Patient-level analysis 17 
The mean relative distance between the implant shoulder and the bone crest at 18 
implant placement was 1.30mm (SD ± 1.00mm) for S1 and -1.26mm (± 19 
1.22mm) for S2. At the time of loading these distances were 0.29mm (± 20 
0.44mm) for S1 and 0.22mm (± 0.43mm) for S2. At the one-year follow-up, 21 
these distances were 0.37mm (± 0.39mm) for S1 and 0.39mm (± 1.02mm) for 22 
S2. The median marginal bone levels at the one-year follow-up were statistically 23 
significantly different between the two groups and in favor of group S2 24 
 15 
(p=0.008). The median bone level changes were statistically significant for both 1 
groups (p<0.001) between implant placement and prosthesis insertion, but not 2 
between prosthesis insertion and the one-year follow-up (S1 p=0.342; S2 3 
p=0.532). A full overview is given in Table 2. 4 
No statistically significant influence was observed in terms of median marginal 5 
bone level changes (S1: p=0.331, S2: p=0.919) comparing ICFDPs (S1 n=6; S2 6 
n=11) to nICFDPs (S1 n=27; S2 n=20). Consequently, there was no association 7 
between either treatment group S1 and S2 or the type of reconstruction on bone 8 
level (p=0.084). 9 
The crown to implant ratio did not demonstrate any statistically significant 10 
differences between the two groups and ranged from 1.09 and 1.19 (p>0.05). 11 
 12 
Clinical and esthetic outcome measures 13 
Implant-level analysis: 14 
The results of the clinical parameters (PPD, BOP, PII, REC, KMb) are reported in 15 
the Table 3a. Table 3b shows the esthetic parameters (Jemt, CH, PHm, PHd, GT) 16 
for the different time-points.  17 
 18 
Patient-level analysis:  19 
No statistically significant differences were observed between the groups and 20 
between prosthesis insertion and the one-year follow-up with respect to clinical 21 
and esthetic parameters (p>0.05). The papilla at the mesial (Jemt mes) (S1: 22 
TP1:1.72 (SD ±0.68) / TP2:1.84 (±0.69); S2 TP1: 1.85 (±0.72) / TP2: 2.00 23 
(±0.73)) and distal (Jemt dist) aspect (S1: TP1: 1.46 (±0.58) / TP2: 1.52 24 
 16 
(±0.51); S2: TP1: 1.32 (±0.75) / TP2: 1.58 (±0.77)) increased in both groups, 1 
but not statistically significantly (p>0.05). The crown height (CH) demonstrated 2 
a slight tendency for an increase in both groups: S1 (TP1: 9.79 (± 1.33); TP2: 3 
9.88 (± 1.49)) (p=0.694) and S2 (TP1: 9.74 (± 1.77); TP2: 10.03 (± 2.09)) 4 
(p=0.124). All data are displayed in Tables 3c & 3d. 5 
 17 
Discussion 1 
The current study revealed a 100% implant survival rate during the first year of 2 
loading for both implant types with a non-matching implant-abutment junction. 3 
At the one-year follow-up, no significant differences were observed in terms of 4 
mean marginal bone levels between the two systems on patient level. A higher 5 
rate of technical and biological complications was observed for S1 during the 6 
one-year follow-up. 7 
 8 
Dental implants demonstrate long-term survival rates of more then 90% over 5 9 
and 10 years (Buser, et al. 1996, Gotfredsen 2012, Jemt 2008, Jung, et al. 10 
2013). These results were reported in private practice settings, specialized 11 
clinics, and university settings (Buser, et al. 2012, Jemt & Lekholm 2005, 12 
Krennmair, et al. 2010, Schneider, et al. 2012). Only a few implant systems 13 
reported long-term clinical data on implant and prosthesis level.(Jung, et al. 14 
2012, Pjetursson, et al. 2012). The outcomes of the present study confirm these 15 
results on a short-term basis with no implants lost during the one-year follow-16 
up. Both systems, S1 and S2 rendered similar outcomes with respect to the 17 
survival rate and demonstrated that they can be used on a daily basis with 18 
predictable outcomes supporting fixed reconstructions.  19 
 20 
Both implant types are designed to be placed with the implant shoulder at the 21 
level of the surrounding bone. In the present study, the relative distances 22 
between the implant shoulder and the bone crest ranged between -4.92mm and 23 
 18 
0.65mm. This indicated that in many cases, implants were placed below the 1 
bone crest, mainly for prosthetic reason. At time of implant placement (TP0), S2 2 
implants were placed deeper with respect to the bone crest than were S1 3 
implants. In a dog study, it was shown that a more vertical sink depth at time of 4 
implant placement influences the changes of the marginal bone levels within the 5 
first 6 months (Jung, Jones, Higginbottom, Wilson, Schoolfield, Buser, Hammerle 6 
& Cochran 2008). These early biologic remodeling processes were 7 
radiographically documented in the present study. Radiographs were taken at 8 
implant placement (TP0), after insertion of final prosthesis (TP1 – baseline) and 9 
after one year of functional loading (TP2). The distances between the shoulder of 10 
the implants and the marginal bone levels changed from implant placement to 11 
baseline and from baseline to one year later. These bone remodeling processes 12 
observed between baseline and one year of functional loading may not be 13 
exclusively considered a physiologic adaptation, but may reflect adapting 14 
changes elicited mainly due to bacterial infection as assumed in the Consensus 15 
Report of the Senventh European Workshop of Periodontology (Lang, et al. 16 
2011). However in contradiction to the mentioned consensus report, also 17 
mechanical loads could play a role in the long-term bone level changes around 18 
dental implants (Marcelis, et al. 2012). In the present study, marginal bone level 19 
changes from implant placement to the one-year follow-up differed between the 20 
two implant systems. S2 implants demonstrated less marginal bone loss 21 
between implant placement and loading with the final prosthesis. S1 implants 22 
implant lost less marginal bone between loading and the one-year follow-up. 23 
Overall, for both systems, the biologic adaptation continued during the 1-year 24 
 19 
observation period. At the one-year follow-up, no significant differences were 1 
observed in terms of mean marginal bone levels between the two systems on 2 
the patient level. The marginal bone levels observed in the present study are 3 
consistent with those reported in previous clinical studies for both systems 4 
(Buser, et al. 2009, Gulje, et al. 2013, Hammerle, et al. 2012). For S1 implants, 5 
a mean marginal bone level at the time of loading of 0.1mm (SD ± 0.04mm) 6 
below the reference point was reported in a clinical study with 36 consecutive 7 
patients. Fifty-three implants were inserted in combination with an osteotome 8 
sinus floor elevation technique. Abutment connection was performed 3 to 4 9 
month later and implants loaded one month later with prosthetic reconstructions. 10 
One year later, the corresponding mean marginal bone level was 0.5mm (± 11 
0.06mm) (Fermergard & Astrand 2008). This is in agreement with the outcomes 12 
of a multicenter study, reporting minimal marginal bone level changes from 13 
implant placement to 3 and 12 months and a marginal bone level slightly below 14 
the implant shoulder at the last follow-up(Donati, et al. 2008). Comparatively, in 15 
the present study, mean marginal bone levels were 0.29mm (± 0.44mm) at the 16 
time of loading and 0.37mm (± 0.39mm) one year later. Data on S2 implants 17 
were reported in a randomized, controlled multi-center clinical trial. In that 18 
study, marginal bone loss was compared differentiating between implants in two 19 
healing modes (submerged versus transmucosal healing). One hundred seventy-20 
seven fixed reconstructions were seated 6 month after implant placement. 21 
Reported marginal bone level changes were -0.47mm for the submerged group 22 
and -0.48mm for the transmucosal group (Hammerle, Jung, Sanz, Chen, Martin, 23 
Jackowski & Multicenter study 2012). 24 
 20 
 1 
Technical complications of the fixed reconstructions were only observed in one of 2 
the two groups (S1). The most common complications were screw loosening and 3 
fractures of screws. On the implant level, 7 of 54 S1 Implants (13%) showed 4 
technical complications. However, one single patient suffered from a fractured 5 
screw (single crown at position 36) and two screw loosenings (FDP at position 6 
46-x-44). The screws were retightened, but then fractured at a later time-point. 7 
Moreover, a major ceramic chipping was observed for the same FDP. This 8 
relatively high rate of technical complications in one single patient may be 9 
explained by the fact that this patient reported bruxism during the night. Based 10 
on a recently published systematic review (Manfredini, et al. 2014), implant 11 
therapy in patients with bruxism does not lead to more biological, but more 12 
technical complications on the reconstruction level. Additionally, two screw 13 
fractures occurred in a FDP (12-x-x-22), in a single crown (25) supported by a 14 
CAD/CAM abutment, whereas a screw loosening was observed at a single crown 15 
(25). This in turn, resulted, on the patient level, in 4 of 33 S1 implants (12%) 16 
with technical complications. In a clinical study using S1 implants, patients 17 
received implant-supported yttria-stabilized tetragonal zirconia polycrystal fixed 18 
dental prostheses (Y-TZP FDPs). At the 3-year follow-up, all FDPs were in use 19 
and none of the reconstructions had fractured. However, superficial chip-off 20 
fractures of the veneering porcelain were observed in 14% (14 units in 7 21 
patients) at 12 month (Larsson, et al. 2010). For FDPs made of porcelain-fused 22 
to metal, technical complications are reported at a level of 16% at 5 years for 23 
this specific implant system (Wennstrom, et al. 2004). For S2 implants, no long-24 
 21 
term data are available. Short-term clinical studies, however, report abutment 1 
screw loosening occurring at a rate of 18.2% in one study and just one porcelain 2 
fracture on one single crown during a 15-month follow-up period in 60 patients 3 
with 60 implants (Barter, et al. 2012, Santing, et al. 2013).  4 
 5 
In the present study, two biological events were observed in the S1 group (6%) 6 
and one biological event in the S2 group (3.2%) upon patient-level analysis 7 
during the one-year loading period. This included two implants in each group 8 
with a mucositis (BOP at all six sites around the implants) and one implant with 9 
bone loss >2mm (S1). The 6th European Workshop on Periodontology defined 10 
mucositis as an inflammatory lesion that affects the soft tissue, whereas peri-11 
implantitis also affects the supporting bone, and in its final stages leads to 12 
implant loss. It also confirmed that both mucositis and peri-implantitis are of 13 
infectious origin (Figuero, et al. 2014, Lindhe, et al. 2008). The prevalence of 14 
peri-implant infections varies. In a study with 216 patients, 73% of the patient 15 
showed a peri-implant mucositis and 56% showed a periimplantitis (Roos-16 
Jansaker, et al. 2006). More recent data of 99 patients with 351 implants 17 
showed BOP and bone loss with ≥ 3 mm in 11.3% of the patients, whereas 18 
47,1% of the patients had BOP and ≥ 2 mm bone-loss (Koldsland, et al. 2010). 19 
Data of the present clinical study are in line with previous observations and a 20 
reported rate of 9% of the patients with peri-implant disease (Behneke, et al. 21 
2000).  22 
 22 
Conclusions 1 
In conclusion, the present study demonstrated 100% survival rates for both two-2 
piece implant systems over the short-term observation period of one year of 3 
loading. The relative distances between the bone crest and the flat top of the 4 
implant shoulder were shorter, thereby representing higher marginal bone levels 5 
in the S2 group for the implant level analysis and higher for the S1 group for the 6 
patient level analysis. Radiographically assessed marginal bone level alterations 7 
were minimal between loading and the one-year follow-up. Few biological and 8 
technical complications occurred. Overall, minimal differences were observed 9 
between the two groups. Therefore, within the limitations of this study, both 10 
implant systems can be recommended to support fixed implant-borne 11 
reconstructions. 12 
 23 
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Figure legends 1 
Table 1. Type of reconstructions on implant- and patient-level for both systems 2 
(S1 and S2). FDP = fixed dental prosthesis. ICFDP = implant-supported 3 
cantilever fixed dental prosthesis 4 
 5 
Table 2. Radiographic data of marginal bone levels (DIB) at implant placement 6 
(TP0), insertion of final prosthesis (baseline, TP1), at the one-year follow-up 7 
examination (TP2) and changes between time-points (TP1-TP0 and TP2-TP1). 8 
Implant- and patient-level analysis with means and standard deviations (SD) 9 
and with medians and interquartile range (IQR) for both implant systems (S1 10 
and S2). P-values for the patient-level analysis were calculated with the non-11 
parametric Mann-Whitney test and non-parametric paired Wilcoxon test to 12 
assess the influence of time. 13 
 14 
Table 3a. Clinical parameters (PPD= probing depth, BOP= bleeding on probing, 15 
PCR= plaque control record, REC= recession and KMb= keratinized tissue on the 16 
buccal site) for both implant systems (S1 and S2) at insertion of final prosthesis 17 
(baseline, TP1) and at the one-year follow-up examination (TP2). Implant-level 18 
analysis with means and standard deviations (SD).  19 
 20 
Table 3b. Esthetic parameters (Jemt mes= mesial papilla contour 21 
measurements, Jemt dist= distal papilla contour measurements, CH = crown 22 
height, PHm= mesial papilla height, PHd = distal papilla height, GT= thickness of 23 
 25 
the attached gingiva) for both implant systems (S1 and S2) at insertion of final 1 
prosthesis (baseline, TP1) and at the one-year follow-up examination (TP2). 2 
Implant-level analysis with means and standard deviations (SD).  3 
 4 
Table 3c. Clinical parameters (PPD= probing depth, BOP= bleeding on probing, 5 
PCR= plaque control record, REC= recession and KMb= keratinized tissue on the 6 
buccal site) for both implant systems (S1 and S2) at insertion of final prosthesis 7 
(baseline, TP1) and at the one-year follow-up examination (TP2). Patient-level 8 
analysis with means and standard deviations (SD). P-values calculated with non-9 
parametric Mann-Whitney test and non-parametric paired Wilcoxon test to asses 10 
the influence of time. 11 
 12 
Table 3d. Esthetic parameters (Jemt mes= mesial papilla contour 13 
measurements, Jemt dist= distal papilla contour measurements, CH = crown 14 
height, PHm= mesial papilla hight, PHd = distal papilla hight, GT= thickness of 15 
the attached gingival) for both implant systems (S1 and S2) at insertion of final 16 
prosthesis (baseline, TP1) and at the one-year follow-up examination (TP2). 17 
Patient-level analysis with means and standard deviations (SD). P-values 18 
calculated with non-parametric Mann-Whitney test and non-parametric paired 19 
Wilcoxon test to assess the influence of time. 20 
 21 
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Tables and Figures 
 
Table1. 
 Implant-level  Patient-level  
 S1 S2 S1 S2 
single crown 29 13 19 12 
splinted single crowns 4 2 2 0 
FDPs 13 15 6 8 
ICFDPs 8 13 6 11 
 
Table 2. 
DIB Implant-
level 
     Patient- 
level 
        
 S1   S2   S1    S2     
 Mean  
SD  
(mm) 
Median 
IQR 
(mm) 
Range 
(mm) 
min  
max 
Mean  
SD  
(mm) 
Median 
IQR 
(mm) 
Range 
(mm) 
min 
max 
Mean 
SD 
(mm) 
Median 
IQR 
(mm) 
Range 
(mm) 
min 
max 
Paired 
p-value 
Mean 
SD 
(mm) 
Median 
IQR 
(mm) 
Range 
(mm) 
min 
max 
Paired 
p-value 
p-
value 
TP0 -1.07 
±0.94 
-1.01 
±1.37 
-4.01  
0.59 
-1.21 
±1.13 
-1.15 
±1.01 
-4.92 
0.65 
-1.30 
±1.00 
-1.37 
±1.15 
-4.01 
0.59 
 -1.26 
±1.22 
-1.20 
±1.12 
-4.92 
0.65 
 0.55 
TP1 0.39 
±0.53 
0.37 
±0.39 
-1.09  
2.82 
0.21 
±0.40 
0.09 
±0.39 
-0.42 
1.70 
0.29 
±0.44 
0.36 
±0.44 
-1.09 
1.00 
 0.22 
±0.43 
0.09 
±0.36 
-0.31 
1.70 
 0.028* 
Difference 
TP1 –TP0 
1.44 
±0.94 
1.37 
±1.54 
-0.44  
3.50 
1.42 
±1.08 
1.16 
±1.31 
-0.55 
0.94 
 
1.58 
±0.93 
1.62 
±1.47 
-0.44 
3.39 
<0.001* 
 
1.48 
±1.16 
1.16 
±1.34 
-0.55 
0.70 
<0.001* 0.371 
TP2 0.49 
±0.62 
0.39 
±0.29 
-1.22 
3.76 
0.34 
±0.88 
0.15 
±0.39 
-0.44 
5.23 
0.37 
±0.39 
0.36 
±0.33 
-1.22 
0.97 
 0.39 
±1.02 
0.14 
±0.38 
-0.44 
5.23 
 0.008* 
Difference 
TP2 –TP1 
0.07 
±0.28 
0.02 
±0.25 
-0.17 
4.92 
0.13 
±0.75 
0.00 
±0.18 
-0.48 
4.69 
0.04 
±0.23 
0.01 
±0.26 
-0.17 
4.92 
0.342 0.17 
±0.86 
0.00 
±0.13 
-0.48 
4.69 
0.532 0.752 
 
Table 3a. 
Implant-
level 
PPD  BOP  PII  REC    KMb  
 S1 S2 S1 S2 S1 S2 S1  S2  S1 S2 
 Mean 
SD 
(mm) 
Mean 
SD 
(mm) 
Mean 
SD 
(%) 
Mean 
SD 
(%) 
Mean 
SD 
(%) 
Mean 
SD 
(%) 
Mean 
SD 
(mm) 
Range 
(mm)  
min 
max 
Mean 
SD 
(mm) 
Range 
(mm) 
min 
max 
Mean 
SD 
(mm) 
Mean 
SD 
(mm) 
TP1 3.09 
±0.55 
2.89 
±0.77 
25 
±21 
24 
±18 
5 
±11 
7 
±14 
0.01 
±0.05 
0.00 
0.33 
0.03 
±0.09 
0.00 
0.50 
2.91 
±1.19 
3.09 
±1.48 
TP2 3.13 
±0.73 
3.07 
±0.61 
26 
±20 
27 
±23 
4 
±10 
4 
±10 
0.02 
±0.87 
0.00 
0.50 
0.20 
±0.96 
0.00 
6.00 
2.83 
±1.25 
3.16 
±1.57 
Difference 
TP2-TP1 
0.04 
±0.89 
0.19 
±0.98 
1 
±23 
3 
±26 
-1 
±11 
- 3 
±15 
0.01 
±0.09 
-0.17 
0.50 
0.17 
±0.96 
-0.50 
6.00 
-0.08 
±1.02 
0.07 
±0.67 
 
Table 3b. 
Implant- 
level 
Jemt  
mes 
 Jemt  
dist 
 CH  PHm  PHd  GT  
 S1 S2 S1 S2 S1 S2 S1 S2 S1 S2 S1 S2 
 Mean 
SD 
(0-4) 
Mean 
SD 
(0-4) 
Mean 
SD 
(0-4) 
Mean 
SD 
(0-4) 
Mean 
SD 
(mm) 
Mean 
SD  
(mm) 
Mean 
SD 
(mm) 
Mean 
SD 
(mm) 
Mean 
SD 
(mm) 
Mean 
SD 
(mm) 
Mean 
SD 
(mm) 
Mean 
SD 
(mm) 
TP1 1.58 
±0.66 
1.73 
±0.77 
1.47 
±0.64 
1.40 
±0.71 
9.87 
±1.40 
9.77 
±1.86 
7.25 
±1.82 
7.54 
±1.61 
7.30 
±1.45 
7.64 
±1.78 
3.33 
±1.48 
3.10 
±1.34 
TP2 1.78 
±0.70 
1.92 
±0.76 
1.51 
±0.67 
1.64 
±0.76 
9.79 
±1.62 
10.12 
±2.46 
7.57 
±2.26 
7.65 
±2.54 
7.48 
±1.44 
7.82 
±2.49 
3.26 
±1.36 
3.07 
±1.38 
Difference 
TP2-TP1 
0.19 
±0.53 
0.19 
±1.00 
0.03 
±0.48 
0.24 
±0.60 
-0.06 
±0.89 
0.35 
±1.13 
0.33 
±1.14 
0.11 
±1.82 
0.15 
±1.08 
0.18 
±1.64 
-0.10 
±1.31 
0.04 
±1.05 
 
Table 3c. 
Patient- 
level 
PPD   BOP   PII   REC     KMb   
 S1 S2  S1 S2  S1 S2  S1  S2   S1 S2  
 Mean 
SD 
(mm) 
Mean 
SD 
(mm) 
p-value Mean 
SD 
(%) 
Mean 
SD 
(%) 
p-value Mean 
SD 
(%) 
Mean 
SD 
(%) 
p-value Mean 
SD 
(mm) 
Range 
(mm)  
min 
max 
Mean 
SD 
(mm) 
Range 
(mm) 
min 
max 
p-value Mean 
SD  
(mm) 
Mean 
SD 
(mm) 
p-value 
TP1 3.13 
±0.51 
 
2.83 
±0.88 
 24 
±22 
21 
±18 
 7 
±13 
8 
±15 
 0.01 
±0.06 
0.00 
0.33 
0.03 
±0.10 
0.00 
0.50 
 3.15 
±1.23 
3.23 
±1.54 
 
TP2 3.05 
±0.54 
3.01 
±0.59 
 25 
±20 
27 
±25 
 5 
±12 
5 
±11 
 0.02 
±0.09 
0.00 
0.50 
0.21 
±1.08 
0.00 
6.00 
 3.12 
±1.34 
3.26 
±1.55 
 
Difference 
TP2-TP1 
0.09 
±0.82 
0.18 
±1.11 
0.165 1 
±23 
6 
±27 
0.477 - 2 
±13 
- 3 
±16 
0.639 0.01 
±0.09 
-0.17 
0.50 
0.18 
±1.09 
-0.50 
6.00 
0.963 -0.03 
±1.21 
0.03 
±0.48 
0.165 
Paired p-
value 
0.261 0.393  0.951 0.220  0.842 0.325  0.655  0.916   0.507 0.705  
 
Table 3d. 
Patient-
level 
Jemt 
mes 
  Jemt 
dist 
  CH   PHm   PHd   GT   
 S1 S2  S1 S2  S1 S2  S1 S2  S1 S2  S1 S2  
 Mean 
SD 
(0-4) 
Mean 
SD 
(0-4) 
p-
value 
Mean 
SD 
(0-4) 
Mean 
SD 
(0-4) 
p-
value 
Mean 
SD 
(mm) 
Mean 
SD 
(mm) 
p-
value 
Mean 
SD 
(mm) 
Mean 
SD 
(mm) 
p-
value 
Mean 
SD 
(mm) 
Mean 
SD 
(mm) 
p-
value 
Mean 
SD 
(mm) 
Mean 
SD 
(mm) 
p-
value 
TP1 1.72 
±0.68 
1.85 
±0.72 
 1.46 
±0.58 
1.32 
±0.75 
 9.79 
±1.33 
9.74 
±1.77 
 7.13 
±1.88 
7.22 
±1.63 
 7.30 
±1.35 
7.74 
±1.97 
 3.18 
±1.47 
3.32 
±1.39 
 
TP2 1.84 
±0.69 
2.00 
±0.73 
 1.52 
±0.51 
1.58 
±0.77 
 9.88 
±1.49 
10.03 
±2.09 
 7.45 
±2.38 
7.63 
±2.26 
 7.54 
±1.29 
8.24 
±2.68 
 3.26 
±1.35 
3.26 
±1.52 
 
Difference 
TP2-TP1 
0.13 
±0.50 
0.15  
±0.66 
0.824 0.04 
±0.53 
0.26 
±0.56 
0.171 0.09 
±0.85 
0.29 
±1.01 
0.344 0.32 
±1.01 
0.41 
±1.55 
0.772 0.19 
±1.13 
0.50 
±1.66 
0.580 -0.08 
±1.02 
-0.06 
±0.10 
0.689 
Paired p-
value 
0.157 0.248  0.705 0.059  0.694 0.124  0.088 0.229  0.368 0.236  0.696 0.854  
 
